Allergan Sues Hi-Tech Over Pinkeye Drug Patents
Allergan, together with Senju Pharmaceutical Co. Ltd. and Kyorin Pharmaceutical Co. Ltd., claim that Hi-Tech's abbreviated new drug application submitted to the U.S. Food and Drug Administration for approval to market a version of gatifloxacin ophthalmic solution — the generic form of Zymaxid — infringes two patents.
Zymaxid is in a class of antibiotics called...
Already a subscriber? Click here to login